Otonomy OTO-313 — Treatment of Tinnitus

There are also medications for other conditions which are not objectively measurable like pain for example. Why do you think tinnitus research should be stopped? Because the risk that trial participants take is too high? I think that's everybody's free decision.

 

Maybe a silly question, but Otonomy hasn't published their peer reviewed journal on the detailed results yet, right? (Similar to this for phase I?) We just know it failed but don't have the data yet to sift through ourselves?

 

What I actually said:

This is not relevant though because there is currently a device out there that has objectively measured tinnitus. @DebInAustralia gave extensive feedback about her own experience at The Bionics Institute.

Absolutely not. I infer zero jurisdiction over any participant in any trial that I comment about here. At the end of the day, your risk profile in life is for you to manage; my risk profile in life is for me to manage (which incidentally is why, regarding the individual's 'free' decision, I argued so vehemently here against mandatory COVID-19 jabs).

I heard an interesting quote recently about truth. I can't remember it verbatim but it was something along the lines of, truth has it's own special frequency, which is why we know it when we encounter it because it resonates with us.

I dunno... but what I would actually say about tinnitus curative research right now (and maybe it's something more to do with common-sense than the truth of it) is that I don't get a good vibe from it. But hey, what would I know?

 

Certainly in some way, although it remains to be seen to what degree.

 

A randomized, double-blind, placebo-controlled phase 2 study of intratympanic OTO-313 in patients with moderate to severe subjective tinnitus

 

So it's REALLY official now.

OTO-313 does NOTHING!

 

It doesn't tell us much more we didn't already know, does it? Not even a full publication.